Casey M Tansey
CIK 1474322 · last filed 2026-05-11
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$408.22M
Companies
13
Total Filings
70
Lifetime Open-Market Net
-$9.97M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| MOBI | Director | 547,422 | — | — | $1000.0K | 1 | 2026-05-11 |
| INSP | Director | 26,786 | $42.70 | $1.14M | -$14.14M | 46 | 2026-05-04 |
| HTFL | Director | 3,089,206 | $33.24 | $102.69M | $0 | 1 | 2025-08-11 |
| SI | Director | 133,253 | $18.70 | $2.49M | $600.0K | 1 | 2025-08-05 |
| eFFECTOR Therapeutics, Inc. (EFTRW) Delisted | 10%+ Owner | 136,241 | $0.00 | $82 | -$297.5K | 1 | 2022-05-19 |
| ON24 INC. (ONTF) Delisted | 10%+ Owner | 7,368,405 | $8.10 | $59.68M | $1.50M | 1 | 2021-02-05 |
| ARS Pharmaceuticals, Inc. (SBTX) Delisted | 10%+ Owner | 105,012 | $5.87 | $616.4K | $4.00M | 1 | 2020-12-08 |
| INTERMOLECULAR INC (IMI) Delisted | 10%+ Owner | 0 | — | — | -$34.3K | 1 | 2018-11-13 |
| Intersect ENT, Inc. (XENT) Delisted | Director | 2,546 | $28.24 | $71.9K | $0 | 9 | 2017-06-05 |
| BOX | 10%+ Owner | 11,713,775 | $25.39 | $297.41M | $0 | 1 | 2015-01-30 |
| GWRE | 10%+ Owner | 36,638 | $122.56 | $4.49M | -$2.36M | 3 | 2012-09-25 |
| MXL | 10%+ Owner | 0 | $84.46 | $0 | -$232.6K | 3 | 2012-08-22 |
| IMPERVA INC (IMPV) Delisted | 10%+ Owner | 9,733 | — | — | $0 | 1 | 2011-11-15 |
Recent Filings · Page 6 of 7
70 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2018-10-12 | INSP | Grant (A) | +338 | $13.7K | EDGAR |
| 2018-07-16 | INSP | Grant (A) | +207 | $8.9K | EDGAR |
| 2018-05-09 | INSP | Mixed | +2,355,754 | $3.00M | EDGAR |
| 2017-06-05 | Intersect ENT, Inc. (XENT) Delisted | Grant (A) | +2,546 | $0 | EDGAR |
| 2017-05-10 | Intersect ENT, Inc. (XENT) Delisted | Other (J) | −1,995,433 | $0 | EDGAR |
| 2017-01-20 | Intersect ENT, Inc. (XENT) Delisted | Grant (A) | — | $0 | EDGAR |
| 2016-06-06 | Intersect ENT, Inc. (XENT) Delisted | Grant (A) | — | $0 | EDGAR |
| 2015-06-05 | Intersect ENT, Inc. (XENT) Delisted | Grant (A) | — | $0 | EDGAR |
| 2015-05-11 | Intersect ENT, Inc. (XENT) Delisted | Other (J) | −990,000 | $0 | EDGAR |
| 2015-03-06 | Intersect ENT, Inc. (XENT) Delisted | Other (J) | −990,000 | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.